ICD-10-PCS 2027 procedure code
XW01318Introduction of Daratumumab and Hyaluronidase-fihj into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 8
Short description: Introduce Daratumumab/Hyaluronid in Subcu, Perc, New Tech 8
Code last changed in FY2023 (effective October 1, 2022). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XW01318
XW01318 is the ICD-10-PCS code for a introduction procedure on the subcutaneous tissue using a percutaneous approach with daratumumab and hyaluronidase-fihj (qualifier: new technology group 8). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
With a different device, use XW01348 (stem cells, somatic).
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2023, effective October 1, 2022.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- 1Subcutaneous Tissue
- 5. Approach
- 3Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
- 6. Device / Substance / Technology
- 1Daratumumab and Hyaluronidase-fihj
Includes: Darzalex Faspro(R)
- 7. Qualifier
- 8New Technology Group 8
Other versions of this procedure
Different device / substance / technology
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2023 (effective 10/1/2022): Added
- No changes since FY2023.
Common questions about XW01318
Is XW01318 a valid ICD-10-PCS code for 2027?
- Yes. XW01318 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.